循环miRNA在肝细胞癌治疗及预后评估中的研究进展(4)
[18] Wen Y，Han J，Chen J，et al. Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma [J]. Int J Cancer，2015，137(7)：1679-1690.
[19] Lai YC，Ushio N，Rahman MM，et al. Aberrant expression of microRNAs and the miR-1/MET pathway in canine hepatocellular carcinoma [J]. Vet Comp Oncol，2018，16(2)：288-296.
[20] Zeng H，Zheng J，Wen S，et al. MicroRNA-339 inhibits human hepatocellular carcinoma proliferation and invasion via targeting ZNF689 [J]. Drug Des Devel Ther，2019，13(10)：435-445.
[21] Wang J，Liang H，Ge H，et al. MicroRNA 363 3p inhibits hepatocarcinogenesis by targeting HMGA2 and is associated with liver cancer stage [J]. Mol Med Rep，2019，19(2)：935-942.
[22] Xu CY，Dong JF，Chen ZQ，et al. MiR-942-3p Promotes the Proliferation and Invasion of Hepatocellular Carcinoma Cells by Targeting MBL2 [J]. Cancer Control，2019，26(1)：1073274819846593.
[23] Yang X，Qu S，Wang L，et al. PTBP3 splicing factor promotes hepatocellular carcinoma by destroying the splicing balance of NEAT1 and pre-miR-612 [J]. Oncogene，2018，37(50)：6399-6413.
[24] Li T，Xie J，Shen C，et al. miR-150-5p inhibits hepatoma cell migration and invasion by targeting MMP14 [J]. PLoS One，2014，9(12)：e115577.
[25] Zhu Y，Zhou C，He Q. High miR-139-3p expression predicts a better prognosis for hepatocellular carcinoma： a pooled analysis [J]. J Int Med Res，2019，47(1)：383-390.
(收稿日期：2019-02-23 本文編辑：任 念), http://www.100md.com(杨益波 余保平)
[19] Lai YC，Ushio N，Rahman MM，et al. Aberrant expression of microRNAs and the miR-1/MET pathway in canine hepatocellular carcinoma [J]. Vet Comp Oncol，2018，16(2)：288-296.
[20] Zeng H，Zheng J，Wen S，et al. MicroRNA-339 inhibits human hepatocellular carcinoma proliferation and invasion via targeting ZNF689 [J]. Drug Des Devel Ther，2019，13(10)：435-445.
[21] Wang J，Liang H，Ge H，et al. MicroRNA 363 3p inhibits hepatocarcinogenesis by targeting HMGA2 and is associated with liver cancer stage [J]. Mol Med Rep，2019，19(2)：935-942.
[22] Xu CY，Dong JF，Chen ZQ，et al. MiR-942-3p Promotes the Proliferation and Invasion of Hepatocellular Carcinoma Cells by Targeting MBL2 [J]. Cancer Control，2019，26(1)：1073274819846593.
[23] Yang X，Qu S，Wang L，et al. PTBP3 splicing factor promotes hepatocellular carcinoma by destroying the splicing balance of NEAT1 and pre-miR-612 [J]. Oncogene，2018，37(50)：6399-6413.
[24] Li T，Xie J，Shen C，et al. miR-150-5p inhibits hepatoma cell migration and invasion by targeting MMP14 [J]. PLoS One，2014，9(12)：e115577.
[25] Zhu Y，Zhou C，He Q. High miR-139-3p expression predicts a better prognosis for hepatocellular carcinoma： a pooled analysis [J]. J Int Med Res，2019，47(1)：383-390.
(收稿日期：2019-02-23 本文編辑：任 念), http://www.100md.com(杨益波 余保平)